Salary: £32,548 to £38,883 plus London Allowance of £3,027
Type: Fixed Term
Closing Date: Monday 23 October 2017
Interview Date: Wednesday 01 November 2017
We are looking for a full-time systematic reviewer to join Cochrane Airways for three years to undertake a set of reviews about respiratory conditions. The reviews will use diverse methods and will be conducted in conjunction with the editorial team, international authors, the NIHR Complex Review Support Unit and NICE.
The successful candidate will be a graduate with experience in and enthusiasm for systematic review. The post-holder will be familiar with research synthesis techniques, have excellent collaborative skills, ability to write fluently and effective time management. Knowledge and interest in the work of Cochrane is highly desirable.
The salary for the role will be within the range of £ 32,548- £38,883 plus London Allowance £ 3,027
Cochrane is delighted to announce the official launch of Cochrane Argentina, a new Cochranecentre with a vision to increase the use of best evidence to inform healthcare decision making throughout Argentina.
Cochrane Argentina consists of three institutions working in collaboration: Instituto de Efectividad Clínica y Sanitaria (IECS, Buenos Aires), Instituto Universitario Hospital Italiano (IUHI, Buenos Aires) and Centro Rosarino de Estudios Perinatales (CREP, Santa Fe).
Cochrane Argentina will promote evidence-based decision making in health care by supporting and training new local authors of Cochrane Reviews, as well as working with clinicians, professional associations, policy-makers, patients, and the media to encourage the dissemination and use of Cochrane evidence. Cochrane Argentina’s inaugural Director will be Agustin Ciapponi supported by the leaders of the other two institutions, Juan Franco (IUHI) and Yanina Sguassero (CREP). Together they will offer methodological support, mentoring, and supervision to the region.
Cochrane Argentina is part of Cochrane, a global independent network of researchers, professionals, patients, carers, and people interested in health. Cochrane works with collaborators from more than 130 countries to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Cochrane’s work is recognized as representing an international gold standard for high quality, trusted information.
Director of Cochrane Argentina, Agustin Ciapponi, says this is a hugely exciting opportunity: “The launch of Cochrane Argentina is very important, both to our country and globally. Producing and increasing the dissemination of the best available information on health care is critical for clinicians and patients everywhere in the world.”
Cochrane’s CEO Mark Wilson, warmly welcomed today’s news: “We are delighted by the launch of Cochrane Argentina and look forward to welcoming more Argentine collaborators to our worldwide network of volunteers. I am sure the new Centre will greatly expand the scope, reach, and impact of Cochrane evidence on health and healthcare decision-making across Argentina and the whole of South America. We are continuing to offer through a sales trial programme one-click access to the Cochrane Library in Argentina, and downloads of Cochrane Systematic Reviews have increased by nearly 900% in the last two years. This is tremendously encouraging as we seek to help clinicians, researchers, policymakers, patients and the general public improve health outcomes across the country.”
Juan Franco (IUHI) added: “This is an innovation for our region and we intend to collaborate in the production and dissemination of Cochrane reviews to continue supporting Cochrane to reach its 2020 strategic objectives.”
Daniel Comandé (IECS), one of the Center’s Information Specialists says: “Cochrane Argentina will promote recognition of studies conducted and published in this country and this will not only simply increase the access of evidence, but also promote sharing of clinical experiences across South America and the world.
For more information on Cochrane’s work within Argentina, please visit the Cochrane Argentina website.Thursday, October 26, 2017
Based at: University of York - Heslington Campus
Hours of work: Full-time
Contract status: Fixed term
Salary: £38,832 - £47,772 Per year
Apply by: 29/10/2017
Applications are invited for the post of Cochrane Managing Editor for the Common Mental Disorders Group within the Centre for Reviews and Dissemination at the University of York.
You will have experience of international research management or scientific/medical publishing. With knowledge of the scientific methods used in health-related research and systematic reviews, you will be able to lead the management and publishing aspects of the CMD Group. Your knowledge and understanding of the work of the Cochrane Collaboration and systematic reviews is an essential component of the role. You will be able to demonstrate excellent time management skills in prioritizing and organizing work and past success in delivering large scale projects to fixed deadlines. You will have good communication and interpersonal skills, and be able to think creatively and strategically to solve problems.
You will be required to draw on specialist expertise and skills, including independent decision-making, to:
- maintain and develop clear working practices to govern the activities of the multidisciplinary consortium of international clinical and research teams;
- advise and assist on the scientific and editorial aspects of CMD review production;
- provide a lead for the financial and legal administration of CMD resources;
- act as key contact between the members of the CMD and between the CMD and the wider Cochrane Collaboration, Wiley-Blackwell and NIHR, towards the fulfilment and delivery of the output of the CMD.
You will have a first degree in a relevant health, science or social science subject and a relevant masters-level qualification. A PhD in a relevant subject is desirable. You will have a track record of successfully managing international collaborative health/scientific research OR scientific publishing, including preparation/delivery of scientific and/or financial reports and applications to funding bodies or publishers.
Based at: University of York - Heslington Campus, UK
Hours of work: Full or part-time
Contract status: Fixed term
Salary: £31,604 - £38,832 per year
Apply by: 29/10/2017
Applications are invited for a Grade 6 Systematic Review Research Fellow based at the Centre for Reviews and Dissemination (CRD) at the University of York to work primarily on Cochrane reviews.
You will be a key member of the Cochrane Common Mental Disorders (CMD) editorial team, working as part of multi-disciplinary teams to deliver CMD systematic reviews and other evidence synthesis projects, often to tight deadlines. You will contribute to all aspects of CMDs systematic reviews including screening articles for inclusion, quality and risk of bias assessment, data extraction, data collection, data management, data synthesis (quantitative and qualitative), interpreting results and writing research reports and papers, with appropriate skills to contribute to other types of synthesis including individual participant data and network meta-analyses, within the CMD group and, where appropriate, other CRD research projects. You may also work on developing methods both within reviews and as standalone projects.
Working under the supervision of the Co-ordinating Editor of the CMD group you will provide support and guidance on methodological aspects of systematic reviews, and will collaborate with a range of CMD review teams at all stages of the review writing and editorial process. You will actively contribute to editorial team meetings and communicate effectively with other team members. Presentation of CMDs work at internal and external meetings and at conferences is also an expectation of the role.
You will have a first degree in a relevant health, science or social science subject and a relevant masters-level qualification. A PhD in a relevant subject is desirable. We are particularly keen to encourage applications from those who have an excellent understanding and previous experience of undertaking systematic reviews in mental health, and prior experience of health related research.
Breast Cancer Awareness Month happens every October and is a month which organizations around the world concentrate their efforts on raising awareness about the disease.
Cochrane Breast Cancer's objective is to provide the best source of accurate and up-to-date information, especially about the prevention, early detection, treatments, follow-up care, and supportive practices for women diagnosed with breast cancer. Their Cochrane Reviews continue to be an integral part of national and international clinical best practice guidelines and their development of Plain Language Summaries provide evidence to policymakers and members of the community in easy to understand language.
- Visit the Cochrane Breast Cancer website
- Read the Evidently Cochrane blog post 'Breast Cancer: your treatment, your choice.'
Read the top five accessed Plain Language Summaries in the last year:
- Screening for breast cancer with mammography
- Drainage tube placement after lymph gland removal from the armpit for breast cancer
- Different types of implants for reconstructive breast surgery after mastectomy
- Regular self-examination or clinical examination for early detection of breast cancer
- Manual lymphatic drainage for lymphedema following breast cancer treatment
We hope you enjoyed the Global Evidence Summit in Cape Town. Your feedback is important, please fill in our short survey on your experiences of the event here: surveymonkey.com/r/GESummit
The Global Evidence Summit was the first time that Cochrane, The Campbell Collaboration, Guidelines International Network, International Society for Evidence-based Health Care, and Joanna Briggs Institute have joined forces to create this premiere event in evidence-based policy.
The theme of the Summit was ‘Using evidence. Improving lives’ and aimed to advance the use of reliable research evidence in addressing some of the world’s most serious health and social challenges. Attendees from across the world were exposed to an illuminating line-up of content and world-class speakers and facilitators that intrigued and engaged wide audiences. We were also treated to an astonishing array of social events and entertainment including talented performers from the Drum Café, gumboot dancing, and the Marimba band. Here are just a few highlights from the week that was, The Global Evidence Summit 13 – 17th September 2017.Community Experience
- #thingswelearnt at #GESSummit17: a twitter summary.
- Blog post by Evidence Synthesis Team.
- Networking session between senior health researchers and students.
- Cochrane Croatia celebrates the GES
- The Nordic Cochrane Centre at GES Summit 2017
- Evidence in a Post-Truth World - Global Evidence Summit 2017: Blog post by a Ph.D. student who attended the GES.
- Cochrane Africa officially launches; a network with a vision to increase the use of best evidence to inform healthcare decision-making across the sub-Saharan African continent.
- Promoting evidence-based health care in Africa; interview with the Director of Cochrane South Africa.
Cochrane's community recognizes success : Find out more about new initiatives to get involved with our work and share with the community and beyond.
How Cochrane's partners recognize and define our success: Cochrane's partnerships play an essential role in developing and sharing our evidence with key people and organizations across the health community.
Patients and their stories: Three stories about how Cochrane evidence has affected people's lives and how these experiences have contributed to Cochrane's work.Tweet from GES
On Saturday 16 September several students from a school near Cape Town attended the morning plenary at the Global Evidence Summit. The students go to school at the Centre Of Science and Technology (COSAT). They were accompanied by their principal and two mentors from the Children’s Radio Foundation who are training them to create radio journalism on public health topics. Following the plenary the students interviewed each of the presenting experts on the topic of evidence in a post-truth world.Wednesday, September 27, 2017
Students and teachers play an important role in Cochrane. They are involved in educating the next generation of healthcare professionals about evidence-based medicine, directly contributing to a global effort of identifying health evidence, to translating Cochrane evidence in 14 different languages.
Hanna Martikainen conducts PhD research at Paris Diderot University on the French-language translation of Cochrane Systematic Review abstracts. Having previously worked as a translation coordinator and post-editor for Cochrane France, she now teaches a class in post-editing medical LSP at the Department of Cross-Cultural Studies and Applied Languages (EILA) at Paris Diderot University. During the past academic year (2016-2017), second year Master’s students in specialized translation have had a unique opportunity to contribute to the French translation project by post-editing machine-translated Cochrane abstracts and Plain Language Summaries. The project has been renewed for the coming academic year and the students have shared their experience here.
Marie, Angèle, Margarita, Pierre, and Pauline described the profiles and general background of students in their second year Master’s degree in specialized translation: "We are a group of 20 students from the ILTS (Industrie de la Langue et Traduction Spécialisée) Master’s degree at Paris Diderot University This course is open to students with prior translation experience in which is the case for most of us, but also to students who have technical experience and who speak at least two languages. None of our courses had trained us to domedical translation. Each one of us had the opportunity to post-edit five medical texts for Cochrane. It was a great experience because we discovered a new field and a new way to work with languages.”
Vera, Marie, Lionelle, Marion, and Justine explained their post-editing work: "Post-editing consists of editing automatic translation produced by a machine. You may already have used machine translation such as Google Translate. Post-editing will undoubtedly play an important part in the future of translation since it will help improve productivity and reduce costs. During the post-editing process, we often had to rephrase or rearrange long and complex sentences, and fix mistranslations, grammatical errors, and inconsistencies."
Nadjet, Mélanie, Pauline, and Lucie noted the specificities of medical English and their importance when translating: "We noticed that English terms do not necessarily belong to languages for specific purposes (LSP), they often seem very simplified. In French, it is quite the opposite since specialized terminology of Latin origin is almost the only one to be used in both LSP and general language.Also the use of passive sentences in English is very common, while we are instructed to avoid them in French as much as possible.”
Joanna, Maya, Camille, Bruno, and Mickaël discussed how their pre-conceived expectations compared to the reality of post-editing: "We thought it would be necessary to have medicine-related knowledge. In reality, the first paragraphs gave us a good grasp of the subject. We simply needed to do some extra research to make sure the terminology was accurate and we had correctly understood the process of thought. Ofcoursethe machine version is not entirely reliable but it was far more efficient than we expected."
Post-editing machine-translated Cochrane texts gave the students a hands-on introduction not only to this recent and booming domain of translation industries, but also to the specificities of medical translation. Moreover, the experience was a professionalizing one, given that the student post-editions were all published on Cochrane websites with acknowledgment given to post-editors.If you are a student, learn about the many ways you can get involved with Cochane:
- Students for Best Evidence: a network for students interested in evidence-based healthcare
- Translate Cochrane evidence: learn about translating Cochrane materials
- Cochrane Crowd: become a Cochrane citizen scientist.
- Join Cochrane: help us improve the health of people everywhere
Cochrane is delighted to announce the official launch of its new, online introductory training course on how to conduct a systematic review of interventions.
As part of the launch of Cochrane’s new online learning programme, Cochrane Interactive Learning, Cochrane authors and other producers of systematic reviews from across the world will be able to access self-directed learning on framing a review, searching for studies, risk of bias assessment, meta-analysis, GRADE and the complete systematic review process, developed by world-leading experts in systematic review methods.
Cochrane Interactive Learning is a new offering from Cochrane, a global, independent network of researchers, professionals, patients, carers and people interested in health. The online learning modules will promote evidence-based decision making in healthcare globally by supporting and training authors of Cochrane Reviews and other systematic reviews of healthcare interventions.
New learners will have the chance to embark on modular, interactive training on how to produce systematic reviews, and experienced authors and can refresh their skills with the latest guidance and best practice.
Miranda Cumpston, Cochrane’s Head of Learning and Support, says this is a hugely exciting opportunity: “Our new online training course offers dynamic, flexible and engaging content with nine modules and over 100 bite-size learning units, building knowledge for new and existing authors one step at a time. They provide clear explanations with stimulating interactions, quizzes, animations, examples and reference resources, and enable learners to tailor their learning experience, in their own time, and from anywhere in the world, from a laptop, tablet or phone.”
Charlotte Pestridge, CEO of Cochrane Innovations, adds “Cochrane Interactive Learning will also serve educators in evidence-based health care, providers of professional development to researchers or health professionals, researchers within guideline development or HTA settings, commercial research organisations, and commissioners of systematic reviews who rely on rigorous methods to make evidence-informed decisions.”
The first four modules of Cochrane Interactive Learning are available now for free trial access for individuals and institutions.
Find out more:
Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health.
Cochrane produces reviews which study all of the best available evidence generated through research and make it easier to inform decisions about health. These are called systematic reviews.
Cochrane is a not-for profit organisation with collaborators from more than 120 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Our work is recognised as representing an international gold standard for high quality, trusted information.
Follow us on twitter @cochranecollab
If you are a journalist or member of the press and wish to receive news alerts before their online publication or if you wish to arrange an interview with an author, please contact the Cochrane press office: email@example.comTuesday, September 19, 2017
Cochrane, a global independent network of researchers, professionals, patients, carers and people interested in health will be holding the 25th annual Cochrane Colloquium at the Edinburgh International Conference Centre in Scotland from 15th to 18th September 2018. It will be hosted by Cochrane UK.
The theme of the Colloquium will be:
‘Cochrane for all – better evidence for better health decisions’
This will be a Colloquium for everyone. It will welcome newcomers to Cochrane from all parts of the world and from all backgrounds. One of the key aims is to increase the involvement of patients, carers and family members (healthcare consumers) in our work. As such, the Colloquium 2018 will be a Patients Included event that is co-designed, co-produced and co-presented by healthcare consumers and where everyone’s input is valued equally.
The Colloquium 2018 will focus on the key goals of Cochrane’s Strategy to 2020, looking through the eyes of healthcare consumers and in partnership with them:
- Producing evidence
- Making evidence accessible
- Advocating for evidence
- Effective and sustainable organization
Martin Burton, Director of Cochrane UK, said: “We have been asked why our focus is on patients, when Cochrane has so many different stakeholders, and we know that all stakeholders ultimately share the same goal – better health for patients. We believe we can best achieve this by working together as equal partners.
We want to make this an inclusive, inspiring and accessible event. We also want to build on our existing work involving and engaging with consumers, to take this engagement to a new level after the event is over”.
For more on the rationale behind making the 2018 Colloquium a ‘Patients Included’ event, you can read a blog here co-authored by Cochrane Consumer Co-ordinator Richard Morley, and Cochrane UK's Director Martin Burton and Sarah Chapman. At the bottom of the blog there is a survey inviting suggestions for making the Colloquium a ‘Patients Included’ event.
More detail on dates, registration, and the scientific programme will be announced in the coming months.
Twitter: @CochraneUK #cochraneforall
Registration will open in late 2017.
Communications and Media Consultant, Cochrane UK
I am delighted to announce a new initiative that I believe will transform Cochrane as an evidence-producing and knowledge-diffusing organization. Today, we are proud to launch our new Cochrane Membership scheme, making it easier than ever before for anyone from anywhere in the world to become a part of our global community of supporters and collaborators passionate about improving healthcare decisions.
The Cochrane Membership scheme will enable us to grow our collaboration, attracting many new people with a wider range of experience and skills into our work, and allowing us to recognize their contributions and sustain our global activities for better health outcomes.
Cochrane’s past, present, and future success is built on the quality of the people it attracts and retains. We are so proud of the tens of thousands of volunteers who already work with us because we know that what we do and the impact for good that we have as an organization are rooted in their efforts. And from today, that world is becoming wider; a world where decisions about health and health care are informed by high-quality, relevant and up-to-date synthesized research evidence.
Today’s announcement is part of the first phase of our Membership scheme, which will evolve and expand in the coming months and years. I wanted to share with you what this means, how you can make contributions to Cochrane’s work, and be a part of our expanding global community.
Whether you just want to stay close to what we're about and what we're doing; build your health research skills and training; help us translate Cochrane evidence into your language; support us with a financial contribution; or eventually become an independent published author in one of the world's top health journals – the Cochrane Library – we have many ways that you can become part of our work.
Joining Cochrane as a supporter can be a commitment as immediate as screening records to find randomized trials with only five minutes of training as part of Cochrane Crowd; or as demanding and involved as being accepted as an author of a Cochrane Review. Many of our contributors work on Cochrane projects during working hours, others in their spare time, in workplaces or at home. It's up to you, depending on your interests and the time you have to contribute.
We’ve created a central membership database that stores details of Cochrane’s supporters and members and tracks their contributions to Cochrane, whether as an author, translator, Crowd participant, Task Exchange contributor, or a learner. The system will recommend activities to new supporters and members to help them expand your skills, experience, and expertise, making it easier to contribute to Cochrane’s work without increasing the workload of our Cochrane Groups.
Supporters are eligible to become Cochrane members after reaching a threshold of activities linked to their contributions. By becoming a member of Cochrane, you will:
- Develop new skills and interests
- Work with like-minded colleagues and collaborators
- Grow professional and social networks
- Receive world class training from world leading experts in the fields of medicine, health policy, research methodology, and consumer advocacy
- See your contributions recorded and recognized
- Receive discounts for Cochrane’s annual conference registration and Cochrane’s Interactive Learning online training course (Cochrane authors and editorial teams will continue to have free access to all learning resources)
- Influence how Cochrane is run through voting for Governing Board members and resolutions in the Annual General Meeting
To find out more about Cochrane’s work in improving global health decision making and how you can make a difference, visit our Membership pages.
Cochrane Membership signals a huge change for the organization and I’m delighted we are announcing its launch this week at the Global Evidence Summit in Cape Town. Our doors are now open to the world in a new expansive way; everyone is welcome to join us and make a contribution – large or small – to our global mission: an open collaboration of brilliant people from around the world all working together to inform and impact health decision making.
With my very best wishes,
Cochrane’s Chief Executive Officer.
- Find out more about Cochrane, what we do, and who we are.
- Follow us on twitter @cochranecollab
- Join Cochrane now
- For all media enquiries, please Jo Anthony or the Cochrane Press Office
Thursday, September 14, 2017
Four new Cochrane EPOC overviews of reviews show reliable evidence on the effects of different ways of organising, financing, and governing health systems in low-income countries and identify important evidence gaps.
Strengthening health systems in low-income countries is key to achieving universal health coverage and achieving the health-related Sustainable Development Goals. Achieving these goals requires informed decisions about health systems. Systematic reviews on the effects of different health system arrangements are essential for making informed decisions, and many such reviews are available. However, policymakers and other stakeholders may struggle to identify which reviews are reliable and what are the key results.
Broad overviews of the findings of systematic reviews can help policymakers, their support staff, and other stakeholders to identify strategies for addressing problems with how their health systems are organised, financed, and governed and with identifying effective strategies for implementing changes. It can also help to identify needs and priorities for new evaluations of health system arrangements and for systematic reviews.
A team of Cochrane researchers from Argentina, Chile, Norway, and South Africa prepared four overviews of the available evidence from up-to-date systematic reviews about the effects of health system arrangements in low-income countries. They included 124 systematic reviews in the four overviews. For each review, a user-friendly summary of key findings was produced (see http://supportsummaries.org/), enabling users to explore the overview findings in more depth. The summaries include over 480 key messages about the effects of health system arrangements in low-income countries.
An overview of delivery arrangements included 50 systematic reviews that included a total of 919 studies. These reviews found that many delivery arrangements probably have desirable effects, including task shifting or role expansion and strategies for coordinating care.
An overview of financial arrangements included 15 systematic reviews that included a total of 276 studies. The effects of most of the financial arrangements that were reviewed were uncertain. This includes the effects of providing financial incentives and disincentives for health care workers, and the effects of most types of financial incentives and disincentives for people using health services.
An overview of governance arrangements included 21 systematic reviews that included a total of 172 studies. These reviews found that restrictions on medicines reimbursement (pre-authorisation), community mobilisation, and disclosing to the public performance data on health facilities and providers probably have desirable effects. The effects of other governance arrangements that were reviewed were uncertain.
An overview of implementation strategies included 39 systematic reviews that included a total of 1332 studies. These reviews found that many different implementation strategies probably improve professional practice, including educational meetings, educational outreach, practice facilitation, local opinion leaders, audit and feedback, and tailored interventions. Many strategies targeted at healthcare recipients also probably have desirable effects on the use of health care. For example, mass media interventions lead to an increase in immediate uptake of HIV testing and reminders and recall strategies for caregivers probably increase routine childhood vaccination uptake.
Dr Simon Lewin, Joint Co-ordinating Editor of Cochrane’s Effective Practice and Organisation of Care (EPOC) Group and Cochrane author noted that: “These overviews are a key source of evidence for decision makers in low-income countries who are considering options for strengthening the health system in their setting. The overviews use a unique approach, based on user-friendly summaries of each contributing review, and we hope that this will make the evidence identified much more accessible to decision makers and those who support them.”
Dr Andy Oxman, another Cochrane author and a Senior Researcher at the Norwegian Institute of Public Health added: “On the one hand, these overviews show that there is a large body of evidence that can inform decisions about health systems in low-income countries. On the other hand, they show that there are many important gaps in what is known. In addition to using the evidence identified in these overviews to inform their decisions, health policymakers and those who support them should routinely consider rigorously evaluating the effects of decisions to change health system arrangements when there are important uncertainties about the benefits and harms.”
Dr Charles Shey Wiysonge, one of the Cochrane authors and the Director of Cochrane South Africa noted that “These overviews have come at an opportune moment, when African countries are considering the best approaches for achieving Universal Health Coverage. The overviews and the underlying user-friendly evidence summaries – the SUPPORT Summaries - are important resources for constructive engagement and exchange between Cochrane Africa and relevant national stakeholders for evidence-informed health decision making in Africa.”
For more information please contact; Simon Lewin: Simon.Lewin@fhi.no
World-leading dermatologists and their patients are celebrating huge improvements in the treatment of skin diseases like skin cancer, psoriasis, and acne as the Cochrane Skin Group marks its 20th anniversary this week. The effects of the 120 plus published Cochrane Skin Reviews have been far-reaching and have had real impacts on patient care. These include skin cancer, skin allergies, and acne, blistering diseases, hair disorders like alopecia, fungal infections and psoriasis as well as tropical parasitic diseases.
The group is coordinated by the University of Nottingham’s Centre of Evidence Based Dermatology and is part of the global Cochrane network that carries out systematic reviews of primary research covering all areas of health and health policy. Cochrane is internationally recognised as setting the highest standards in evidence-based health care resources.
The effects of the 120 plus published Cochrane Skin Reviews have been far-reaching and have had real impacts on patient care. These include skin cancer, skin allergies and acne, blistering diseases, hair disorders like alopecia, fungal infections and psoriasis as well as tropical parasitic diseases.
“By systematically reviewing and summarising all relevant clinical trials, Cochrane Skin tries to drive up the quality of primary research into skin disease prevention and treatments,” says Professor Hywel Williams, the visionary founder of Cochrane Skin. “A lot of dermatology clinical trials have addressed unimportant questions that mean little to patients, and which have been designed and reported badly. By sorting out the wheat from the chaff, Cochrane Skin draws a line in the sand in order to stimulate better primary research.”
Inspired by a call to action from one of the original Cochrane founders, Sir Iain Chalmers, in the British Medical Journal in 1992, Professor Williams set about building Cochrane Skin, which was officially registered with Cochrane (originally The Cochrane Collaboration) on 12th September 1997.
At present more than 1,300 people from 61 different countries contribute to the work of the Cochrane group, with an established Satellite group in France and others planned in South America and the USA.
From the outset, Cochrane Skin has closely involved patient groups in its work. Maxine Whitton MBE, a co-founder of The Vitiligo Society, was formerly Chairman and is now a Patron, has had the skin pigmentation condition ‘vitiligo’ since childhood. Maxine said:
“Professor Williams encouraged and supported me in producing the first review of interventions for vitiligo. This review retrieved just 19 randomised trials, mostly of poor quality, published since 1966, highlighting the need for more research and well-designed trials as the basis for informed decisions on treatments. We conducted two further Cochrane Skin reviews published in 2010 (57 trials) and 2015 (96 trials).
“The review has stimulated further vitiligo research and projects. For example, the Vitiligo Society has helped us in the recruitment of participants for a pilot study of psychological interventions for vitiligo and also a large multi-centre trial combining topical treatment and NB-UVB for vitiligo (Hi-Light) based at Nottingham, which is ongoing.”
Cochrane Skin will be celebrating its 20th anniversary as the first Global Evidence Summit (GES) takes place in Cape Town, South Africa (13th – 16th September 2017). This event sees Cochrane join with four other leading organisations – the Guidelines International Network, The Campbell Collaboration, the International Society for Evidence-based Health Care, and the Joanna Briggs Institute – to focus on the opportunities and challenges facing low- and middle-income countries. The theme of the GES, ‘Using Evidence. Improving Lives’, will highlight and promote evidence-informed approaches to health policy and development, offering the most cost-effective interventions.
Cochrane Skin is grant-funded by the National Insitute for Health Research (NIHR) Systematic Reviews Programme.
- Visit the Cochrane Skin website
- Read the University of Nottingha blog post
- More information is available from Professor Hywel Williams, Centre of Evidence Based Dermatology, Faculty of Medicine and Health Sciences on +44 (0)115 or email firstname.lastname@example.org or Emma Rayner in the Communications Office at The University of Nottingham, on +44 (0)115 951 5793, email@example.com
The specialist director will be responsible for developing the field of evaluation of interventions in the Division for Health Services, including systematic reviews, health technology assessments (HTAs) and health economic analyses. The specialist director will be responsible for many of the division's and the Norwegian Institute of Public Health's external activities in these fields, including collaboration with external stakeholders within and outside Norway. In autumn 2017, the division will adopt a new organisational structure, with more work in teams and projects. The specialist director, together with the rest of the division’s management group, will be responsible for implementing and further developing the new organisational structure and new working methods within the division.
The Division for Health Services is one of four divisions in the Norwegian Institute of Public Health. We work with health system assessments, evaluation of interventions, dissemination and use of knowledge, and global health. With regard to the evaluation of interventions, the division contributes with systematic reviews on the effect of interventions in the health, care and welfare sectors, as well as systematic reviews on causes of disease and prognosis for various conditions. The division also conducts health technology assessments (HTAs) of new interventions that are relevant for introduction into the health service, where safety, efficacy, costs and other aspects of the interventions are considered. Our target groups are decision makers in health administration, in the health and care services and in the welfare sectors - including healthcare professionals and patients. The division collaborates with a number of key actors in Norway and internationally, including Cochrane and the Campbell Collaboration.
- Participate in the division’s management group and contribute to the overall management of the division together with the executive director and the rest of the management group
- Contribute to optimal resource use across the divisions of the Norwegian Institute of Public Health and across the departments in the division
- Further develop the field of evaluation of interventions and seek to realise the division's development plan for 2018–2022 in this field
- Further develop the field of evaluation of interventions at the Norwegian Institute of Public Health and ensure collaboration and co-ordination of activities across the divisions at the institute
- Implement and further develop new organisational structure and new working methods in the division
- Promote a good working environment and professional development for the division's and institute's employees
- Contribute to open and professional communication at the institute and towards partners, users and the media
- Line manager responsibility (staff, finance, etc.) for one or more departments may be delegated from the executive director. Management of other interdisciplinary functions may also be considered
- Doctoral degree in a field relevant for the post, preferably within the health, natural or social sciences
- High research expertise
- Healthcare expertise
- Significant expertise in systematic reviews and/or health technology assessments
- Management experience
- Wide international network is an advantage
- Good oral and written skills in Norwegian (within 18 months) and English
- Commitment to contributing to better health and health services, both in Norway and globally
- Commitment to management, particularly management promoting team collaboration
- Ability to lead with confidence and clarity
- Ability to inspire and prioritise
- Flexible, solution-oriented and with a strong drive to get things done
- Good collaborative and communication skills
This Cochrane Overview is the first publication produced with the support of Cochrane’s Fast Track service. This service, which is offered by the Cochrane Editorial Unit, supports expedited production of high-quality, high-impact Cochrane Reviews. For more information, please visit the Fast Track information page.
- A new Cochrane Overview has identified effective and safe clinician-focussed interventions to reduce antibiotic prescribing for acute respiratory infections (ARIs) in primary care.
- The authors found that point-of-care CRP testing, procalcitonin-guided management and shared decision making probably safely reduce antibiotic prescribing in the management of ARIs compared to usual care.
- There were no trials in the included reviews which compared interventions against one another, so we do not know which is most effective at reducing antibiotic prescribing for ARIs in primary care.
- Antibiotic resistance has become a major public health problem, with some infections no longer treatable using currently available drugs. The inappropriate use of antibiotics is associated with the increase of resistance.
- Most antibiotics are prescribed in primary care, and most commonly for ARIs. In most cases ARIs seen in primary care are spontaneously resolved without antibiotics.
- The management of ARIs in primary care is therefore a key target for influencing the antibiotic prescribing behaviour of clinicians.
What does the review say?:
- The authors identified eight systematic reviews assessing clinician-focussed interventions to influence antibiotic prescribing for ARIs in primary care, containing a total of 44 trials.
- Moderate-quality evidence suggests that the following interventions probably have an important effect on reducing antibiotic prescribing in primary care:
- C-reactive protein point-of-care testing in general practice probably reduces antibiotic prescribing with little or no effect on symptom duration, patient satisfaction, or reconsultation;
- shared decision making in the management of ARI in general practice probably reduces antibiotic prescribing without increasing likelihood of reconsultation, and may maintain patient satisfaction;
- procalcitonin-guided management of ARI in probably reduces antibiotic prescribing in general practice and emergency departments without affecting health-related quality of life and whilst avoiding treatment failure.
- There were no trials in the included reviews which compared these interventions against one another, so we do not know which is the most effective.
- For the other interventions, including multifaceted interventions, those centred on clinician education, patient information leaflets, and the use of rapid viral diagnostics, the evidence was of low or very low quality across outcomes, and we could not confidently draw any conclusions about the effects of these interventions compared to usual care. Further primary research is necessary to improve the evidence base in order to be able to make informed decisions about the value of these interventions.
- None of the trials in the included reviews reported on management costs for the treatment of an ARI or any associated complications, so it was difficult to weigh the benefits and costs of implementing these interventions in practice.
- Most of this research was undertaken in high-income countries, and it may not generalize to other settings.
Get access to this Cochrane Overview online: Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviewsFriday, September 8, 2017
A very warm welcome to Cape Town! We look forward to welcoming more than 1400 people from at least 67 countries to the first ever Global Evidence Summit.
The Global Evidence Summit will be the first time that Cochrane, The Campbell Collaboration, Guidelines International Network, International Society for Evidence-based Health Care, and Joanna Briggs Institute have joined forces to create this premiere event in evidence-based policy.
The theme of the Summit is ‘Using evidence. Improving lives’ and aims to advance the use of reliable research evidence in addressing some of the world’s most serious health and social challenges. We’ve created an illuminating line-up of content and world-class speakers and facilitators that promises to excite, intrigue and engage wide audiences.
We hope the Summit will provide the fruitful ground for all delegates to meet, share and collaborate to progress our aims. For a full programme schedule visit globalevidencesummit.org/signup.
Enjoy the Summit, and do take some time to explore a little of our beautiful country during your stay with us.
Jimmy Volmink and Tamara Kredo
Chairs of the Organising Committees for the 2017 Global Evidence Summit
The Cochrane Tobacco Addiction Group, based at the University of Oxford in the UK, is one of the oldest groups working on Cochrane Reviews. It has produced dozens of these during the last two decades and in 2016, it embarked on a project to identify the top priorities for future research into tobacco control.
The Cochrane Tobacco Addiction Group's research prioritization exercise involved more than 300 people and identified a total of 183 unanswered questions in tobacco control through two online surveys and an Oxford-based workshop. It identified 24 priority questions, grouped into eight priority themes. This new set of research priorities to support tobacco control will help ensure future research provides the greatest benefit to public health and value for money.
"The range, appearance, and accessibility of tobacco products has changed significantly in recent years," said Dr Jamie Hartmann-Boyce, Senior Researcher and Managing Editor in the Cochrane Tobacco Addiction Group, which is based in Oxford University's Nuffield Department of Primary Care Health Sciences. "Technology has given rise to new ways of delivering nicotine that can help reduce the harms associated with traditional cigarettes.
"To ensure our research continues to address the contemporary issues in tobacco control, we aimed to develop a set of research priorities that represent the views of the widest group possible."
- Read about the findings of the Tobacco Addition Priorities Report
- Read the full report: Setting research priorities in tobacco control: A stakeholder engagement project
- Read the press release from the Nuffield Department of Primary Care Health Sciences, University of Oxford
- Listen to the podcast about how priorities were set and what it covers with Dr Jamie Hartmann-Boyce, Senior Researcher and Managing Editor in the Cochrane Tobacco Addiction Group
- Learn more about the Priority Setting project
- Learn more about the Priority Setting Workshop
- Visit the Cochrane Tobacco Addition Group website
Cochrane announces a three-year agreement to establish a Cochrane Russian Associate Centre at the Kazan Federal University
Cochrane Russia was established at the Kazan Federal University in 2014 and was soon assigned as the national coordinating center for Cochrane. Partnering together they have launched two master programs (in evidence-based medicine and pharmacology), held several international conferences, a national round-table of evidence based medicine, courses for new systematic reviewers, and published many systematic reviews. An agreement has been recently signed that will have Kazan Federal Univerity hosting Cochrane Russia for the next three years.
Cochrane CEO, Mark Wilson said: “I’m delighted to sign this three-year agreement with Rector Gafurov to establish a Cochrane Russia Associate Centre at the Kazan Federal University. Followed up with the appropriate resourcing it provides a great opportunity for the KFU and Cochrane to develop evidence-informed medicine in the Russian Federation and establish KFU’s leadership in this area. There is so much potential for Cochrane evidence to make a huge contribution to improving Russia’s health outcomes; and we are looking forward to working further with Lilia Ziganshina, the Cochrane Russia team, and her colleagues at KFU to accomplish this.”
We are pleased to announce the publication of our organizational Dashboard for the second quarter of 2017. This Dashboard, which we publish quarterly, presents our achievements in a series of key metrics, such as publishing output, Cochrane Library usage, and progress on meeting Strategy to 2020 targets. Work on Strategy targets is covered in more detail in the Target Report below.
This initiative is part of Cochrane’s commitment to organizational transparency. For everyone interested in Cochrane and our work, these critical indicators provide an opportunity to monitor our production and dissemination of evidence, and our organizational health.
Highlights from the second quarter include:
- Global usage of Cochrane.org continues its quarter-by-quarter growth; now exceeding 3.5m sessions in the quarter.
- 62% of Cochrane.org usage is viewing non-English content. Usage is soaring in South America. Mexico has become the top user of Cochrane.org, replacing USA for the first time and exceeding half a million sessions in a quarter for the first time.
- Sales and royalties year to date are excellent. Royalties year to date are up 24.5% compared with the same period last year.
For more information:
Covidence is one of Cochrane’s recommended tools to support you in some of the most labour-intensive stages of your systematic review, saving up to 35% of researcher time. Covidence allows your team to upload search results, screen abstracts and full text, complete data collection, conduct risk of bias assessment, resolve disagreements and export data into RevMan or Excel. Covidence is free to use for all Cochrane reviews, and is designed to be intuitive and user-friendly.Want to know more about Covidence?
Give it a try and let us know what you think!Visit Covidence
The Covidence platform continues to evolve, with recent product updates advancing the tool towards the vision of a world where answers to questions about health and other fields of human wellbeing are accurate, up to date and accessible. The Covidence team is committed to engaging with the Cochrane community and continuing to make improvements that are user-focused. Significant improvements have been made recently to data extraction and to importing.Covidence at Global Evidence Summit
The Covidence team will be at stand 13A at the Global Evidence Summit in Cape Town. Please say hello and let us know how your research is going! In addition, two workshops will be held: Introduction to Covidence, and Covidence Forum. Introduction to Covidence is a complete walk-through of the tool designed for novice users. Covidence Forum is intended for individuals already familiar with Covidence, and will share more in-depth tips and have additional time for discussion and feedback.Recent updates
Additional customisation during data extraction
Covidence has a streamlined data extraction form with many of the standard elements pre-programmed, minimising time research teams have to spend on constructing their forms. You can see a walkthrough of creating a data extraction form in Covidence here.
You’ll see that there have been several recent additions to make the form even more flexible. You can now create custom effect measures, in which the data type collected in the table can be an integer, a decimal, a percentage, or even free text for qualitative outcomes. Furthermore, these data types are now validated, so the system will flag for users when a data point differs from the indicated type. Custom text fields can also be added to several sections of the form, so if there’s information you’d like to capture that isn’t covered in the standard form, you can create a place for it.Improved Imports
You can now view your import history directly from your review dashboard. In addition, in response to feedback that the de-duplication process was unclear, it is now displayed more explicitly in this improved review history on the dashboard. Finally, the structure of the importer has been significantly improved leading to faster and more stable imports!What’s coming next
Upcoming work will focus on building relationships directly with each Cochrane Review Group to lay foundations for further integration between Archie / Cochrane and Covidence. Our intention is that in the future, reviews will be automatically created under the Cochrane Review Group in Covidenceas soon as they are registered, making it seamless for teams to begin work as soon as they’d like. Each review will be associated with a specific group account in Covidence, which will also enable editorial team members to easily see an overview of how everyone is going. Your Covidence homepage will look similar to the accompanying image, with reviews collated by review group for easy organisation.Have some ideas on how to continue improving Covidence?
Thank you for voicing your feedback and user needs, these are an invaluable input into our product roadmap and prioritisationprocess. The Covidenceteam would love to hear more from you! Please contact CovidenceSupport at firstname.lastname@example.org if you’d like to share some ideas, have a chat, or just say hello!Thursday, August 24, 2017
Cochrane is delighted to announce the official launch of Cochrane Africa; a network with a vision to increase the use of best evidence to inform healthcare decision making across the sub-Saharan African continent.
The Africa Network consists of regional centres including its co-ordinating centre at Cochrane South Africa, South African Medical Research Council, and the establishment of hubs at University of Calabar, Teaching Hospital, Nigeria, Stellenbosch University, South Africa and Yaoundé University, Cameroon.
Cochrane Africa is part of the global, independent Cochrane network of researchers, professionals, patients, carers, and people interested in health. The Network will promote evidence-based decision making in health care across the sub-Saharan African region by supporting and training new authors of Cochrane Reviews, as well as working with clinicians, professional associations, policy makers, patients, and the media to encourage the dissemination and use of Cochrane evidence.
Since the late 1990s, African collaborators have worked to improve the production of high-quality, Africa-relevant reviews and to support their use in policy and practice through stakeholder engagement and capacity building. In 2007, the informal Cochrane Network was created to build on this track record and to enhance and expand these activities.
Reviews from Africa have informed several national and international guidelines, particularly in the areas of malaria, tuberculosis, and HIV/AIDS.
Cochrane Africa Founding Director Jimmy Volmink warmly welcomed today’s news: “Cochrane SA has been investing in building capacity and relationships on the African continent over many years, and it is now wonderful to see the vision of a formally registered Cochrane African Network coming to fruition.”
Cochrane Africa will be co-ordinated by Cochrane SA, which will offer methodological support, mentoring, and supervision to the regions.
The Director of Cochrane South Africa, Charles Wiysonge, says this is a hugely exciting opportunity: “The launch of the first-ever Cochrane Africa Network is very important, both to sub-Saharan Africa and globally. Producing and increasing the dissemination of the best-available information on health care is critical for clinicians and patients everywhere in the world, including Africa. We wish to build partnerships to promote evidence-informed health care in collaboration with African leadership, and create further opportunities to grow the network.”
Solange Durão from the Cochrane Africa Coordinating Unit is proud to be a part of this Network: “Health care will benefit from the increased presence of Cochrane’s work in sub-Saharan Africa. Conducting relevant reviews based on priority setting, identification of research gaps, and regional stakeholder needs is going to stimulate and focus our actions relating to the care of patients based on strong scientific evidence. Many African countries will benefit from this collaboration as we welcome new contributors to build capacity by providing learning and mentoring opportunities for conducting and using relevant Cochrane systematic reviews.”
Cochrane’s CEO Mark Wilson says: “I believe this is an important announcement for improved health outcomes in Africa. The continent’s health and healthcare challenges are huge, and with limited resources and fragile health systems in many countries it is more important than anywhere else in the world that the decisions of Africa’s doctors, nurses and policy-makers are made on the basis of the best evidence. Cochrane Africa will deepen and expand the scope, reach, and impact of Cochrane evidence on health and healthcare decision making; as well as developing Africa’s own production of high-quality evidence amongst its clinicians, researchers and academics. I’m delighted we are launching Cochrane Africa, our newest geographic network, at the Global Evidence Summit in Cape Town as an indication of Cochrane’s growing commitment to overcoming the global inequalities in healthcare provision and life chances that continue to exist.”
West Africa Hub
Martin Meremikwu and Emmanuel Effa
Calabar Institute of Tropical Diseases Research & Prevention
University of Calabar Teaching Hospital
Francophone Africa Hub
Pierre Ongolo-Zogo and Lawrence Mbuagbaw
Centre for the Development of Best Practices in Health
Yaoundé Central Hospital
Cochrane Africa Coordinating Unit
Tamara Kredo, Solange Durão, Charles Wiysonge and Taryn Young
Cochrane South Africa
South African Medical Research Council
W: www.mrc.ac.za/cochrane or southafrica.cochrane.org
Tuesday, August 22, 2017